Rasmussen L F, Ahlfors C E, Wennberg R P
J Clin Pharmacol. 1978 Oct;18(10):477-81. doi: 10.1002/j.1552-4604.1978.tb01575.x.
The primary albumin binding site of indomethacin is remote from the bilirubin binding site. Indomethacin is, at most, a weak displacer of bilirubin at low serum drug concentrations. When administered at dosages less than 1 mg/kg, indomethacin would appear to be safe with respect to serum binding of bilirubin in premature infants.
吲哚美辛的主要白蛋白结合位点远离胆红素结合位点。在低血清药物浓度下,吲哚美辛充其量只是胆红素的一种弱置换剂。当以低于1mg/kg的剂量给药时,就早产婴儿胆红素的血清结合而言,吲哚美辛似乎是安全的。